Table 1.
Group | 5th day PI (mean±SD) | 10th day PI (mean±SD) | 15th day PI (mean±SD) | 20th day PI (mean±SD) |
---|---|---|---|---|
Group 1: (Infected non-treated control) | 42.6±8.3 | 55.6±15.8 | 85.4±12.6 | 176.2±45.3 |
Group 2: (Infected treated with MTZ 10 mg/kg) | 34.3±2.5a | 37.4±5.0a | 36.2±4.3a | 36.3±51.4a |
Group 3A: (Infected treated with AVA 20 mg/kg) | 29.2±3.8a,b | 29.2±4.1a,b | 20.2±14.5a,b | 11.5±14.6a,b |
Group 3B: (Infected treated with AVA 40 mg/kg) | 20.9±6.7a,b | 17.1±7.2a,b | 16.1±4.3a,b | 3.6±11.7a,b |
Group 4A: (Infected treated with AVA 20 mg/kg & MTZ 10 mg/kg) | 14.8±5.3a,b | 11.5±2.4a,b | 8.5±3.3a,b | 3.33±3.27a,b |
Group 4B: (Infected treated with AVA 40 mg/kg & MTZ 10 mg/kg) | 8.1±3.3a,b | 6.4±2.8a,b | 1.21±3.11a,b | 1±2.2a,b |
Values are expressed as mean±SD.
Statistically significant compared to infection control group=P-value<0.05.
Statistically significant compared to MTZ treated group=P-value<0.05.